Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice

Journal of Ethnopharmacology

Volumn 112, Issue 1, 2007, Pages 40-48

  Lee, Young Cheol ^a   Kim, Seung Hyung ^b   Roh, Seong Soo ^b   Choi, Ho Young ^c   Seo, Young Bae ^b  

^a Department of Computer and Electronic Physics   (South Korea)

^b Daejeon University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Arthritis; CD4+CD25+ regulatory T cell; Chelidonium majus; IFN ; IL 6; TNF

Indexed keywords

CHELIDONIUM EXTRACT; COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; METHANOL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFECT; DRUG ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PANNUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CHELIDONIUM; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HINDLIMB; IMMUNOLOGIC FACTORS; JOINTS; KOREA; LYMPH NODES; MALE; MEDICINE, ORIENTAL TRADITIONAL; METHANOL; MICE; MICE, INBRED DBA; PLANT EXTRACTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOLVENTS; SPLEEN; T-LYMPHOCYTES;

BOVINAE; CHELIDONIUM MAJUS; MUS;

EID: 34247871177     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.01.033     Document Type: Article

References (28)

1. Colombo M.L., and Bosisio E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacological Research 33 (1996) 127-134
2. Corthay A., Johansson A., Vestberg M., and Holmdahl R. Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. International Immunology 11 (1999) 1065-1073
3. Dolhain R.J., van der Heiden A.N., ter Haar N.T., Breedveld F.C., and Miltenburg A.M. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis and Rheumatism 39 (1996) 1961-1969
4. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
5. Hori S., Takahashi T., and Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Advances in Immunology 81 (2003) 331
6. Janossy G., Panayi G., Duke O., Bofill M., Poulter L.W., and Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte/macrophage immunoregulation. Lancet 2 (1981) 839-842
7. Kadowaki K.M., Matsuno H., Tsuji H., and Tunru I. CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clinical and Experimental Immunology 97 (1994) 212-218
8. Kery A., Horvath J., Nasz I., Verzar-Petri G., Kulcsar G., and Dan P. Antiviral alkaloid in Chelidonium majus L. Acta Pharmaceutica Hungarica 57 (1987) 19-25
9. Kim H.K., Farnsworth N.R., Blomster R.N., and Fong H.H. Biological and phytochemical evaluation of plants. V. Isolation of two cytotoxic alkaloids from Chelidonium majus L. Journal of Pharmaceutical Sciences 58 (1969) 372-374
10. Koch A.E. Review: angiogenesis: implications for rheumatoid arthritis. Arthritis and Rheumatism 41 (1998) 951-962
11. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., Russell A., Dougados M., Emery P., Nuamah I.F., Williams G.R., Becker J.C., Hagerty D.T., and Moreland L.W. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. The New England Journal of Medicine 349 (2003) 1907-1915
12. Küpeli E., Kosar M., Yesilada E., Husnu K., and Baser C. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sciences 72 (2002) 645-657
13. Lee S.I., Hyun P.M., Kim S.H., Kim K.S., Lee S.K., Kim B.S., Maeng P.J., and Lim J.S. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a Natural Product Library. Arthritis and Rheumatism 52 (2005) 345-353
14. Lenfeld J., Krontil M., Marsalek E., Slavik J., Preininger V., and Simanek V. Anti-inflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Medica 43 (1981) 161-165
15. Luross J.A., and Williams N.A. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103 (2001) 407-416
16. Mitra S., Sur R.K., Roy A., and Murherjee A.S. Effect of Chelidonium majus L. on experimental hepatic tissue injury. Phytotherapy Research 10 (1996) 354-356
17. Morgan M.E., Sutmuller R.P., Witteveen H.J., van Duivenvoorde L.M., Zanelli E., Melief C.J., Snijders A., Offringa R., de Vries R.R., and Toes R.E. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis and Rheumatism 48 (2003) 1452
18. Morgan M.E., Flierman R., van Duivenvoorde L.M., Witteveen H.J., van Ewijk W., van Laar J.M., de Vries R.R., and Toes R.E. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25 regulatory T cells. Arthritis and Rheumatism 52 (2005) 2212-2221
19. Quayle A.J., Chomarat P., Miossec P., Kjeldsen-Kragh J., Forre O., and Natvig J.B. Rheumatoid inflammatory T-cell clones express mostly Th1 but also Th2 and mixed (Th0-like) cytokine patterns. Scandinavian Journal of Immunology 38 (1993) 75-82
20. Saglam H., and Arar G. Cytotoxic activity and quality control determinations on Chelidonium majus. Fitoterapia 74 (2003) 127-129
21. Takemura S., Klimiuk P.A., Braun A., Goronzy J.J., and Weyand C.M. T cell activation in rheumatoid synovium is B cell dependent. Journal of Immunology 167 (2001) 4710-4718
22. Tin-Wa M., Kim H.K., Fong H.H., and Farnsworth N.R. The structure of chelidimerine, a new alkaloid from Chelidonium majus. Lloydia 35 (1972) 87-89
23. Tran C.N., Lundy S.K., and Fox D.A. Synovial biology and T cells in rheumatoid arthritis. Pathophysiology 12 (2005) 183-189
24. Vahlensieck U., Hahn R., Winterhoff H., Gumbinger H.G., Nahrstedt A., and Kemper F.H. The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver. Planta Medica 61 (1995) 267-271
25. Williams R.O., Whyte A., and Waldmann H. Resistance to collagen induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. Autoimmunity 4 (1989) 237-245
26. Wolfe F., and Hawley D.J. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. Journal of Rheumatology 25 (1998) 2108-2117
27. Wooley P.H., and Chapedelaine J.M. Immunogenetics of collagen-induced arthritis. Critical Reviews in Immunology 8 (1987) 1-22
28. Yesilada E., and Küpeli E. Berberis crataegina DC. Root exhibits potent anti-inflammatory, analgesic and febrifuge effects in mice and rats. Journal of Ethnopharmacology 79 (2002) 237-248